The American Psychedelic Practitioners Association (APPA) has released the first-ever set of professional practice guidelines for psychedelic-assisted...
Atai Life Sciences (NASDAQ: ATAI) reported its second quarter 2023 financial results and provided corporate updates. At this time Atai has no revenue to...
Have you ever heard of the Jedi Mind Fuck mushrooms? These psychedelic fungi are one of the most potent magic mushrooms around. Learn all about it...
Two-thirds of participants with major depressive disorder or generalized anxiety disorder reported improvement. The post Enthea, Dr. Bronner’s Post ‘Eye-Opening’...
Atai noted it was exploring strategic options for the study. The post Atai May Step Away from Ketamine Study After Releasing Positive Results appeared...
Atai announced results from Perception Neuroscience’s Phase 1 intravenous-to-subcutaneous bridging study of PCN-101 (R-ketamine). The post atai Life...
Who won the awards on the final night of the Diggers and Dealers forum in Kalgoorlie and which lithium explorer ... Read More The post Diggers...
If the ayahuasqueros of the world united, they could create a human chain stretching from Madrid to Moscow and back. This interesting tidbit is based on...
it's important to ensure that psychedelic therapy is accessible to those who need it and is conducted in a safe and ethical manner. The post Psychedelic-Assisted...
Local markets are flat at lunchtime, despite a push among banking stocks and some huge lithium news for Iris Metals. ... Read More The post ASX...
Scientists from the Wildlife Conservation Society (WCS), the Ministry of Environment, and the Ministry of Agriculture Forestry and Fisheries of the Royal...
Filament Health Corp. (OTCQB: FLHLF / NEO: FH / FSE: 7QS), a clinical‐stage natural psychedelic drug development company, today announced approval from...
FDA has approved two clinical trials studying the effects of PEX010, Filament's botanical psilocybin drug candidate. The post Filament Health Announces...
The FDA gave the nod to the University of Washington and UCLA. The post FDA Greenlights University Research of Filament Psychedelic Drug appeared first...
Algernon NeuroScience has completed a feasibility study and has finalized its clinical trial design for a 40 patient Phase 2 DMT Stroke study. The post...